PHARM.AS AMS
Pharming Group N.V.
1W: -6.2%
1M: -10.6%
3M: -30.4%
YTD: -36.5%
1Y: -30.4%
3Y: -25.0%
5Y: +4.7%
€0.87 ($0.98)
-0.02 (-1.76%)
Weekly Expected Move ±4.6%
€1
€1
€1
€1
€1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$44M
+2653.1% ▲
5Y CAGR: -13.4%
Capital Expenditures
$664K
+13.0% ▲
5Y CAGR: -47.4%
Free Cash Flow
$44M
+1846.3% ▲
5Y CAGR: -10.2%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$71M
+1149.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $22M | $15M | -$12M | -$11M | $3M |
| Depreciation & Amort. | $19M | $13M | $16M | $16M | $10M |
| Stock-Based Comp. | $9M | $6M | $9M | $11M | $0 |
| Change in Working Capital | -$5M | -$387K | -$17M | -$7M | $13M |
| Other Non-Cash Items | -$8M | -$11M | -$14M | -$10M | $19M |
| Operating Cash Flow | $36M | $23M | -$17M | -$2M | $44M |
| — Investing Activities — | |||||
| Capital Expenditures | -$16M | -$2M | -$1M | -$736K | -$669K |
| Acquisitions (Net) | $0 | $7M | $0 | $0 | -$58M |
| Investment Purchases | -$4M | $0 | -$382M | -$263M | -$657K |
| Investment Sales | $0 | $0 | $233M | $293M | $76M |
| Other Investing | -$0 | $6M | $21M | $2M | -$888 |
| Investing Cash Flow | -$20M | $5M | -$129M | $32M | $16M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3M | -$3M | -$5M | -$34M | -$4M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$30M | -$4M | $4M | -$5M | -$518K |
| Financing Cash Flow | -$27M | -$5M | -$1M | -$34M | $13M |
| Net Change in Cash | $3M | $15M | -$146M | -$7M | $71M |
| Cash End of Period | $192M | $207M | $62M | $55M | $124M |
| Free Cash Flow | $20M | $21M | -$19M | -$2M | $44M |